Regenerative medicine is an innovative approach to medicine that will make it possible to overcome diseases that are difficult to treat with conventional medicine. It also represents a new industry in which high growth is anticipated. Regenerative medicine is still in its infancy with many challenges still remaining, such as conducting research and development of therapeutically effective cells, assuring safety, reducing cell production costs, establishing cell logistics, and establishing hospitals for regenerative medicine. It is hoped that regenerative medicine will enter widespread use, overcoming these challenges and establishing the capabilities to deliver high-quality cells to hospitals in sufficient quantities and at a reasonable cost. In addition to engaging in research and development aimed at commercializing and popularizing the latest basic and applied research through a process of open innovation, Hitachi will bring together the technology and knowhow it has acquired through related business activities to establish new cell value chains. In this way it will contribute to the creation of a society in which everyone can live a long and healthy life with access to the benefits of regenerative medicine.
Center for Exploratory Research, Research & Development Group, Hitachi, Ltd. She is currently engaged in the research and development of regenerative medicine. Dr. Takeda is a member of The Japanese Society for Regenerative Medicine (JSRM), The Molecular Biology Society of Japan (MBSJ), and the Tissue Engineering and Regenerative Medicine International Society (TERMIS).
